Akebia Therapeutics, Inc. Income Statement

Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.53M181.23M207.74M10.00M294.64M211.65M292.48M10.00M160.18M
Cost of Revenue 7.77M145.34M296.48M150.67M85.57M74.15M63.18M
Gross Profit 199.97M-135.34M-1.83M60.98M206.92M-64.15M97.00M
Operating items
Amortization - Intangibles 1.52M36.40M32.62M36.04M36.04M36.04M36.04M
Depreciation & Amortization - Total 0.90M2.20M2.10M1.90M1.65M1.58M1.46M
Research & Development 115.78M230.89M291.01M322.97M218.49M147.85M129.99M63.08M37.65M
Selling, General & Administrative 22.21M27.01M87.06M149.46M154.10M174.14M138.60M100.23M106.55M
Restructuring Costs 15.93M0.18M0.06M
Other Operating Expenses -331.12M-322.66M1.33M1.31M1.59M1.52M-0.52M1.76M
Operating Expenses 138.00M257.90M378.13M475.95M375.99M325.48M287.69M166.73M147.47M
Operating Income -136.46M-76.67M-178.16M-286.29M-377.83M-264.50M-80.78M-46.26M-50.47M
EBIT -136.46M-76.67M-178.16M-286.29M-377.83M-264.50M-80.78M-46.26M-50.47M
Non-operating items
Interest & Investment Income 0.90M2.80M6.15M0.79M-8.87M-19.94M-15.69M-6.03M-18.18M
Other Non Operating Income -0.19M0.20M0.08M-0.79M1.86M2.41M3.15M0.89M-0.52M
Non Operating Income -0.19M0.20M0.08M-0.79M1.86M2.41M3.15M0.89M0.09M
Net income details
EBT -135.75M-73.67M-171.93M-286.29M-384.84M-282.02M-94.23M-51.92M-69.41M
Tax Provisions -28.34M-6.63M
Profit After Tax -135.75M-73.67M-143.59M-279.66M-384.84M-282.02M-94.23M-51.92M-69.41M
Income from Continuing Operations -135.75M-73.67M-143.59M-279.66M-384.84M-282.02M-94.23M-51.92M-69.41M
Consolidated Net Income -135.75M-73.67M-143.59M-279.66M-384.84M-282.02M-94.23M-51.92M-69.41M
Income towards Parent Company -135.75M-73.67M-143.59M-279.66M-384.84M-282.02M-94.23M-51.92M-69.41M
Net Income towards Common Stockholders -135.75M-73.67M-143.59M-279.66M-384.84M-282.02M-94.23M-51.92M-69.41M
Additional items
EPS (Basic) -3.60-1.69-2.47-2.36-2.78-1.70-0.52-0.28-0.33
EPS (Weighted Average and Diluted) -2.36-2.78-1.70-0.52-0.28-0.33
Shares Outstanding (Weighted Average) 38.83M47.27M57.06M129.86M144.54M174.96M183.96M188.39M218.18M
Shares Outstanding (Diluted Average) 118.40M138.46M165.95M182.78M187.47M210.95M
EBITDA -135.79M-74.07M-143.41M-279.40M-384.83M-282.03M-94.23M-51.92M-69.41M
Tax Rate 16.48%2.32%